GV (Google Ventures)

Activity from announced rounds

Activity in this selectionUnited States

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
33
Confirmed lead rounds
1
26 roles undisclosed
New companies
31
First participation on record · 2 follow-on
Funding in participating rounds
$21.3B
33 disclosed · full round size, not this investor’s share

By stage

Series C+11
Series B8
Series A6
Undisclosed4
Seed3
1 more
Growth1

By primary sector

Biotech7
Healthtech6
AI5
Cybersecurity5
Developer tools2
7 more
Fintech2
Climate tech1
Defense tech1
Enterprise software1
Foodtech1
Mobility1
Space tech1

By country

United States33

Rounds

33 in this selection
EpiBiologics

Develops bispecific antibodies for targeted degradation of extracellular proteins.

$107MSeries B
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed
Prudentia Sciences

Provides AI-native due diligence for life sciences dealmaking

$20MSeries A
Role not disclosed